Description
MGCD-265 Analog is an inhibitor of MET that may exhibit anticancer potential.
Product Unit Size | Cost | Quantity | Stock |
---|
MGCD-265 Analog is an inhibitor of MET that may exhibit anticancer potential.
Cas No. | 875337-44-3 |
---|---|
Purity | ≥98% |
Formula | C26H20FN5O2S2 |
Formula Wt. | 517.60 |
Chemical Name | N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide |
IUPAC Name | N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide |
Synonym | MGCD-265; MGCD265; MGCD 265 Analog, MGCD265 Analog, MGCD-265 Analog, Glesatinib Analog |
Solubility | DMSO 104 mg/mL (200.92 mM) Water Insoluble Ethanol Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Belalcazar A1, Azaña D, Perez CA, et al. Targeting the Met pathway in lung cancer. Expert Rev Anticancer Ther. 2012 Apr;12(4):519-28. PMID: 22500688.
Carnitine derivative, involved in energy homeos...
β-lactam; penicillin binding protein inhibitor...
Endogenous peptide, involved in stress signalin...
Expectorant.
GRP analog, found in Bombina; bombesin and GRP ...
Aldose reductase inhibitor.
Mixture of oligomycins A, B, C; oxidative phosp...
Antimicrobial peptide found in bee and wasp ven...
PDK1 inhibitor.
PARP inhibitor.
Statin; HMG-CoA reductase inhibitor.
Peptide, cleavage product of proenkephalin; κO...
A peroxisome proliferator-activated receptor ag...
Platelet substitute, peptide; GP IIb/IIIa activ...
Melatonin analog; MT1/2 agonist, 5-HT2C antagon...
Aminoglycoside; protein translation inhibitor, ...
Pentacyclic triterpene.
Found in Discodermia; PP1 and PP2A inhibitor.
CRF-related peptide found in amphibians.
Quinoline, food preservative; HSP90 inhibitor.<...